The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1b study with selinexor, a first in class selective inhibitor of nuclear export (SINE) in patients with advanced sarcomas: An efficacy analysis.
 
Mrinal M. Gounder
Consulting or Advisory Role - Amgen; Daiichi Sankyo
Travel, Accommodations, Expenses - Amgen; Daiichi Sankyo
 
Alona Zer
No Relationships to Disclose
 
William D. Tap
Consulting or Advisory Role - Advaxis; Ariad; EMD Serono; Janssen; Plexxikon
Travel, Accommodations, Expenses - Boehringer Ingelheim
Other Relationship - Morphotek
 
Abha A. Gupta
No Relationships to Disclose
 
Mary Louise Keohan
No Relationships to Disclose
 
Mark Andrew Dickson
No Relationships to Disclose
 
Sandra P. D'Angelo
No Relationships to Disclose
 
Ping Chi
No Relationships to Disclose
 
Lanier R. Tanner
No Relationships to Disclose
 
Theresa Konen
No Relationships to Disclose
 
Tami Rashal
Employment - Karyopharm Therapeutics
Stock and Other Ownership Interests - Karyopharm Therapeutics
 
Dilara McCauley
Employment - Karyopharm Therapeutics
Stock and Other Ownership Interests - Karyopharm Therapeutics
 
Jean-Richard Saint-Martin
Employment - Karyopharm Therapeutics
Stock and Other Ownership Interests - Karyopharm Therapeutics
 
Robert Carlson
Employment - Karyopharm Therapeutics
Stock and Other Ownership Interests - Karyopharm Therapeutics
 
Tracey Marshall
Employment - Karyopharm Therapeutics
Stock and Other Ownership Interests - Karyopharm Therapeutics
 
Sharon Shacham
Employment - Karyopharm Therapeutics
Leadership - Karyopharm Therapeutics
Stock and Other Ownership Interests - Karyopharm Therapeutics
 
Mansoor Raza Mirza
Leadership - Karyopharm Therapeutics
Stock and Other Ownership Interests - Karyopharm Therapeutics
Consulting or Advisory Role - Karyopharm Therapeutics
 
Michael Kauffman
Employment - Karyopharm Therapeutics
Leadership - Karyopharm Therapeutics
Stock and Other Ownership Interests - Karyopharm Therapeutics
 
Gary Schwartz
Honoraria - AstraZeneca; Boston Biomedical; Novartis
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Novartis
 
Albiruni R. A. Razak
Research Funding - Karyopharm Therapeutics